Pattern of Nailfold Capillaroscopy in Patients With Systemic Lupus Erythematosus

Overview

Journal Arch Rheumatol

Specialty Rheumatology

Date 2021 Mar 24

PMID 33758813

Citations 4

Authors

Ting Zhao

Fu-An Lin

Hong-Pu Chen

Affiliations

Soon will be listed here.

Abstract

Objectives: This study aims to assess the nailfold capillary changes in patients with systemic lupus erythematosus (SLE), particularly among those with Raynaud's phenomenon (RP), and the correlation between nailfold capillary changes and autoantibodies and disease activity.

Patients And Methods: A total of 85 patients (9 males, 76 females; median age 31 years; range, 15 to 58 years) with newly diagnosed SLE were selected between July 2016 and July 2018 from our hospital. Disease activity was scored by the SLE Disease Activity Index. Nailfold capillaroscopy (NFC) was performed in all patients.

Results: Normal pattern, non-specific pattern, and scleroderma pattern were found in 13 (15.3%), 64 (75.3%), and eight (9.4%) patients, respectively. There was no significant difference between anti-double stranded deoxyribonucleic acid, anti-Smith antibodies, and low complements (all p>0.05), while significant differences of NFC pattern were found between low disease activity and high disease activity (p=0.002). RP was present in 31.7% of SLE patients, and the NFC findings in SLE patients with and without RP were significantly different in dilatation (81.5% vs. 14.0%).

Conclusion: The results of our study showed that capillary changes were very common in patients with SLE, which seem to associate with disease activity and RP condition.

Citing Articles

The Role of Nailfold Videocapillaroscopy in the Diagnosis and Monitoring of Interstitial Lung Disease Associated with Rheumatic Autoimmune Diseases.

Anghel D, Prioteasa O, Nicolau I, Bucurica S, Belinski D, Popescu G Diagnostics (Basel). 2025; 15(3).

PMID: 39941292 PMC: 11816486. DOI: 10.3390/diagnostics15030362.

Microvascular remodeling after autologous stem cell transplant in an overlap of systemic sclerosis and systemic lupus erythematosus: A case report.

Mumtaz S, Balistreri L, Abril A, Ayala E, Butendieck Jr R, Berianu F SAGE Open Med Case Rep. 2024; 12:2050313X241271811.

PMID: 39185071 PMC: 11342424. DOI: 10.1177/2050313X241271811.

Reversible Cerebral Vasoconstriction Syndrome and Raynaud's Phenomenon: Is There a Link between the Pathogeneses of Their Underlying Complex Etiology? A Case Report and Literature Review.

Alenzi F, DCruz D Diagnostics (Basel). 2023; 13(18).

PMID: 37761318 PMC: 10528332. DOI: 10.3390/diagnostics13182951.

Evaluation of hypertension in systemic sclerosis and systemic lupus erythematosus overlap.

Chew E, Barnado A, Ikizler T, Zent R, Frech T J Scleroderma Relat Disord. 2023; 8(1):14-19.

PMID: 36743818 PMC: 9896192. DOI: 10.1177/23971983221122673.

Nailfold Capillaroscopy With USB Digital Microscopy in Connective Tissue Diseases: A Comparative Study of 245 Patients and Healthy Controls.

Chanprapaph K, Fakprapai W, Limtong P, Suchonwanit P Front Med (Lausanne). 2021; 8:683900.

PMID: 34422857 PMC: 8377356. DOI: 10.3389/fmed.2021.683900.

References

Manfredi A, Sebastiani M, Cassone G, Pipitone N, Giuggioli D, Colaci M . Nailfold capillaroscopic changes in dermatomyositis and polymyositis. Clin Rheumatol. 2014; 34(2):279-84. DOI: 10.1007/s10067-014-2795-8. View

Lambova S, Muller-Ladner U . Capillaroscopic pattern in systemic lupus erythematosus and undifferentiated connective tissue disease: what we still have to learn?. Rheumatol Int. 2012; 33(3):689-95. DOI: 10.1007/s00296-012-2434-0. View

Voilliot D, Magne J, Dulgheru R, Kou S, Henri C, Caballero L . Prediction of new onset of resting pulmonary arterial hypertension in systemic sclerosis. Arch Cardiovasc Dis. 2016; 109(4):268-77. DOI: 10.1016/j.acvd.2015.11.014. View

Kuryliszyn-Moskal A, Klimiuk P, Sierakowski S, Ciolkiewicz M . Vascular endothelial growth factor in systemic lupus erythematosus: relationship to disease activity, systemic organ manifestation, and nailfold capillaroscopic abnormalities. Arch Immunol Ther Exp (Warsz). 2007; 55(3):179-85. PMC: 2765643. DOI: 10.1007/s00005-007-0017-7. View

Higuera V, Amezcua-Guerra L, Montoya H, Masso F, Patlan M, Paez A . Association of Nail Dystrophy With Accrued Damage and Capillaroscopic Abnormalities in Systemic Lupus Erythematosus. J Clin Rheumatol. 2015; 22(1):13-8. DOI: 10.1097/RHU.0000000000000336. View

Selva-OCallaghan A, Fonollosa-Pla V, Trallero-Araguas E, Martinez-Gomez X, Simeon-Aznar C, Labrador-Horrillo M . Nailfold capillary microscopy in adults with inflammatory myopathy. Semin Arthritis Rheum. 2008; 39(5):398-404. DOI: 10.1016/j.semarthrit.2008.09.003. View

Cutolo M, Sulli A, Smith V . How to perform and interpret capillaroscopy. Best Pract Res Clin Rheumatol. 2013; 27(2):237-48. DOI: 10.1016/j.berh.2013.03.001. View

Etehad Tavakol M, Fatemi A, Karbalaie A, Emrani Z, Erlandsson B . Nailfold Capillaroscopy in Rheumatic Diseases: Which Parameters Should Be Evaluated?. Biomed Res Int. 2015; 2015:974530. PMC: 4569783. DOI: 10.1155/2015/974530. View

Moneib H, Salem S, Aly D, Khedr H, Wafaey H, Hassan H . Assessment of serum vascular endothelial growth factor and nail fold capillaroscopy changes in systemic lupus erythematosus with and without cutaneous manifestations. J Dermatol. 2011; 39(1):52-7. DOI: 10.1111/j.1346-8138.2011.01322.x. View

10.

Fiechtner J, Montroy T . Treatment of moderately to severely active systemic lupus erythematosus with adrenocorticotropic hormone: a single-site, open-label trial. Lupus. 2014; 23(9):905-12. PMC: 4232266. DOI: 10.1177/0961203314532562. View

11.

Ciolkiewicz M, Kuryliszyn-Moskal A, Klimiuk P . Analysis of correlations between selected endothelial cell activation markers, disease activity, and nailfold capillaroscopy microvascular changes in systemic lupus erythematosus patients. Clin Rheumatol. 2009; 29(2):175-80. DOI: 10.1007/s10067-009-1308-7. View

12.

Kuryliszyn-Moskal A, Ciolkiewicz M, Klimiuk P, Sierakowski S . Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity. Scand J Rheumatol. 2008; 38(1):38-45. DOI: 10.1080/03009740802366050. View

13.

Cutolo M, Sulli A, Pizzorni C, Accardo S . Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 2000; 27(1):155-60. View

14.

Lambova S, Muller-Ladner U . The role of capillaroscopy in differentiation of primary and secondary Raynaud's phenomenon in rheumatic diseases: a review of the literature and two case reports. Rheumatol Int. 2009; 29(11):1263-71. DOI: 10.1007/s00296-009-1019-z. View

15.

Pavlov-Dolijanovic S, Damjanov N, Vujasinovic Stupar N, Marcetic D, Sefik-Bukilica M, Petrovic R . Is there a difference in systemic lupus erythematosus with and without Raynaud's phenomenon?. Rheumatol Int. 2012; 33(4):859-65. DOI: 10.1007/s00296-012-2449-6. View

16.

Shenavandeh S, Habibi S . Nailfold capillaroscopic changes in patients with systemic lupus erythematosus: correlations with disease activity, skin manifestation and nephritis. Lupus. 2017; 26(9):959-966. DOI: 10.1177/0961203316686702. View

17.

Paxton D, Pauling J . Does nailfold capillaroscopy help predict future outcomes in systemic sclerosis? A systematic literature review. Semin Arthritis Rheum. 2018; 48(3):482-494. DOI: 10.1016/j.semarthrit.2018.02.005. View

18.

van den Hoogen F, Khanna D, Fransen J, Johnson S, Baron M, Tyndall A . 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013; 65(11):2737-47. PMC: 3930146. DOI: 10.1002/art.38098. View

19.

Herrick A, Moore T, Murray A, Whidby N, Manning J, Bhushan M . Nail-fold capillary abnormalities are associated with anti-centromere antibody and severity of digital ischaemia. Rheumatology (Oxford). 2010; 49(9):1776-82. DOI: 10.1093/rheumatology/keq139. View

20.

Ingegnoli F . Capillaroscopy abnormalities in relation to disease activity in juvenile systemic lupus erythematosus. Microvasc Res. 2013; 87:92-4. DOI: 10.1016/j.mvr.2013.02.004. View